After adjusting for age and gender, mitokines in T2D patients were analyzed in relation to the type of treatment, i.e., no treatment (NoT), metformin (Met), sulphonylureas (Sulph), combination of metformin and sulphonylureas (M + S), and insulin (Ins). The gene discussed is INS; the disease is type 2 diabetes mellitus.